Glycosaminoglycan and transforming growth factor β1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy

Fertility and Sterility

Volumn 92, Issue 1, 2009, Pages 320-327

  De Muro, Pierina ^a   Capobianco, Giampiero ^a   Formato, Marilena ^a   Lepedda, Antonio Junior ^a   Cherchi, Gian Mario ^a   Gordini, Laila ^a   Dessole, Salvatore ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

glycosaminoglycans; Transforming growth factor 1; urinary trypsin inhibitor; women

Indexed keywords

CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; TRANSFORMING GROWTH FACTOR BETA1; ULINASTATIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; FERTILIZATION IN VITRO; GESTATION PERIOD; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; OOCYTE RETRIEVAL; OVULATION; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCTION; URINALYSIS;

ADULT; CREATININE; DIURESIS; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GLYCOSAMINOGLYCANS; HUMANS; LYMPHOTOXIN-ALPHA; MENSTRUAL CYCLE; OVULATION INDUCTION; PREGNANCY; REFERENCE VALUES; YOUNG ADULT;

EID: 67649095478     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.05.066     Document Type: Article

References (26)

1. Götte M. Syndecans in inflammation. FASEB J 17 (2003) 575-591
2. Tkachenko E., Rhodes J.M., and Simons M. Syndecans: new kids on the signaling block. Circ Res 96 (2005) 488-500
3. Trowbridge J.M., and Gallo R.L. Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology 12 (2002) 117-125
4. Fraser J.R., Laurent T.C., and Laurent U.B. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242 (1997) 27-33
5. Imanari T., Shinbo A., Ochiai H., Ikei T., Koshiishi I., and Toyoda H. Study on proteoglycans having low-sulfated chondroitin 4 sulfate in human urine and serum. J Pharmacobiodyn 15 (1992) 231-237
6. Faarvang H.J. Urinary trypsin inhibitor in man ("Mingin"). Scand J Clin Lab Invest 17 (1965) 1-78
7. Nakane M., and Iwama H. Intra-alveolar urinary trypsin inhibitor cannot inhibit polymorphonuclear elastase activity in the lung in postsurgical patients with acute respiratory distress syndrome. Surg Today 29 (1999) 1030-1033
8. Shikimi T., Suzuki S., Wessel T., Joh T.H., Hattori K., and Takaori S. Human urinary trypsin inhibitor (urinastatin)-like substance in mouse liver. Life Sci 50 (1992) 1399-1406
9. Hochstrasser K., Schonberger O.L., Lempart K., and Metzger M. Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor. VI. Detection of a complex between immunoglobulin g and the inhibitory active part of the inter-alpha-trypsin inhibitor. Hoppe Seylers Z Physiol Chem 362 (1981) 1363-1367
10. Camaioni A., Hascall V.C., Yanagishita M., and Salustri A. Effects of exogenous hyaluronic acid and serum on matrix organization and stability in the mouse cumulus cell-oocyte complex. J Biol Chem 268 (1993) 20473-20481
11. Kanayama N., el Maradny E., Halim A., Liping S., Maehara K., Kajiwara Y., et al. Urinary trypsin inhibitor prevents uterine muscle contraction by inhibition of Ca++ influx. Am J Obstet Gynecol 173 (1995) 192-199
12. Mulheron G.W., Bossert N.L., Lapp J.A., Walmer D.K., and Schomberg D.W. Human granulosa-luteal and cumulus cells express transforming growth factors-beta type 1 and type 2 mRNA. J Clin Endocrinol Metab 74 (1992) 458-460
13. Polli V., Bulletti C., Galassi A., Borini A., Ciotti P.M., Seracchioli R., et al. Transforming growth factor-beta 1 in the human endometrium. Gynecol Endocrinol 10 (1996) 297-302
14. De Muro P., Faedda R., Formato M., Re F., Satta A., Cherchi G.M., et al. Urinary glycosaminoglycans in patients with systemic lupus erythematosus. Clin Exp Rheumatol 19 (2001) 125-130
15. Cherchi G.M., Formato M., Demuro P., Masserini M., Varani I., and De Luca G. Modifications of low density lipoprotein induced by the interaction with human plasma glycosaminoglycan-protein complexes. Biochim Biophys Acta 1212 (1994) 345-352
16. al-Hakim A., and Linhardt R.J. Capillary electrophoresis for the analysis of chondroitin sulfate- and dermatan sulfate-derived disaccharides. Anal Biochem 195 (1991) 68-73
17. De Muro P., Faedda R., Satta A.E., Masala A., Cigni A., Falconi D., et al. Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity. Scand J Urol Nephrol 41 (2007) 230-236
18. Enghild J.J., Thogersen I.B., Cheng F., Fransson L.A., Roepstorff P., and Rahbek-Nielsen H. Organization of the inter-alpha-inhibitor heavy chains on the chondroitin sulfate originating from Ser(10) of bikunin: posttranslational modification of IalphaI-derived bikunin. Biochemistry 38 (1999) 11804-11813
19. Kanayama N., el Maradny E., Halim A., Maehara K., Kajiwara Y., and Terao T. Urinary trypsin inhibitor suppresses premature cervical ripening. Eur J Obstet Gynecol Reprod Biol 60 (1995) 181-186
20. El Maradny E., Kanayama N., Halim A., Maehara K., Kobayashi T., and Terao T. Effects of urinary trypsin inhibitor on myometrial contraction in term and preterm deliveries. Gynecol Obstet Invest 41 (1996) 96-102
21. Weilke C., Brinkmann T., and Kleesiek K. Determination of xylosyltransferase activity in serum with recombinant human bikunin as acceptor. Clin Chem 43 (1997) 45-51
22. Kobayashi H., Suzuki K., Sugino D., and Terao T. Urinary trypsin inhibitor levels in amniotic fluid of normal human pregnancy: decreased levels observed at parturition. Am J Obstet Gynecol 180 (1999) 141-147
23. Fried G., Wramsby H., and Tally M. Transforming growth factor-beta1, insulin-like growth factors, and insulin-like growth factor binding proteins in ovarian follicular fluid are differentially regulated by the type of ovarian hyperstimulation used for in vitro fertilization. Fertil Steril 70 (1998) 129-134
24. Ogasawara M.S., Aoki K., Aoyama T., Katano K., Iinuma Y., Ozaki Y., et al. Elevation of transforming growth factor-beta1 is associated with recurrent miscarriage. J Clin Immunol 20 (2000) 453-457
25. Dungy L.J., Siddiqi T.A., and Khan S. Transforming growth factor-beta 1 expression during placental development. Am J Obstet Gynecol 165 (1991) 853-857
26. Hatthachote P., and Gillespie J.I. Complex interactions between sex steroids and cytokines in the human pregnant myometrium: evidence for an autocrine signaling system at term. Endocrinology 140 (1999) 2533-2540